| |
| Clinical Advisory Board >>Gerold Nepom |
 |
| |
 |
Gerold Nepom, MD PhD
|
|
| |
| |
Director, Benaroya Research Institute at Virginia Mason and Affiliate Professor of Immunology, University of Washington School of Medicine. Before joining the Benaroya Institute, Dr. Nepom conducted research in the Department of Pathology at Harvard Medical School and the Fred Hutchinson Cancer Research Center at the University of Washington. He is an internationally recognized expert in molecular mechanisms of type 1 diabetes and rheumatoid arthritis and has conducted clinical studies of potential cellular and molecular targets and therapeutic strategies for type 1 diabetes. Dr. Nepom earned his PhD in Biochemistry and his MD from the University of Washington.
|
| |
|
|
 |
|
| February 2011 |
| February 2011 AIRMID partners with Circassia to develop topical PAP-1 |
|
| January 2010 |
| Joe Sum joins
AIRMID Board of Directors |
| July 2009 |
AIRMID partners with Kineta
to develop ShK peptides
|
|
more... |
|
